Optimi Health Corp. Common Shares - Asset Resilience Ratio
Optimi Health Corp. Common Shares (OPTH) has an Asset Resilience Ratio of 0.02% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Optimi Health Corp. Common Shares's working capital to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how Optimi Health Corp. Common Shares's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Optimi Health Corp. Common Shares's balance sheet.
Liquid Assets Composition Over Time
This chart breaks down Optimi Health Corp. Common Shares's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read OPTH current and long-term liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $3.52K | 0.02% |
| Total Liquid Assets | $3.52K | 0.02% |
Asset Resilience Insights
- Limited Liquidity: Optimi Health Corp. Common Shares maintains only 0.02% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Optimi Health Corp. Common Shares Industry Peers by Asset Resilience Ratio
Compare Optimi Health Corp. Common Shares's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Beijing Tongrentang Co Ltd
SHG:600085 |
Drug Manufacturers - Specialty & Generic | 0.50% |
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Neuland Laboratories Limited
NSE:NEULANDLAB |
Drug Manufacturers - Specialty & Generic | 9.65% |
|
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062 |
Drug Manufacturers - Specialty & Generic | 1.18% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
Annual Asset Resilience Ratio for Optimi Health Corp. Common Shares (2021–2025)
The table below shows the annual Asset Resilience Ratio data for Optimi Health Corp. Common Shares.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-09-30 | 0.03% | $5.01K | $15.23 Million | -- |
| 2022-09-30 | 0.00% | $0.00 | $16.82 Million | -- |
| 2021-09-30 | 17.05% | $4.00 Million | $23.46 Million | -- |
About Optimi Health Corp. Common Shares
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and… Read more